# TRELEGY ELLIPTA
> **NDA209482** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2017-09-18
## Drug
- **FDA Application Number:** NDA209482
- **Application type:** New Drug Application
- **Brand name:** TRELEGY ELLIPTA
- **Generic name:** FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE
- **Active ingredients:** FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2017-09-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209482)
---
*MORVS · CC0 1.0*